Fennec Pharmaceuticals Inc.
FENC
$6.01
-$0.27-4.30%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -436.00K | -1.13M | 2.74M | 2.84M | -16.05M |
| Total Depreciation and Amortization | 0.00 | 774.00K | 749.00K | 723.00K | -- |
| Total Amortization of Deferred Charges | 959.00K | 134.00K | 185.00K | 235.00K | 287.00K |
| Total Other Non-Cash Items | 9.51M | 9.35M | 4.66M | 5.87M | 5.39M |
| Change in Net Operating Assets | 16.94M | 14.47M | 14.71M | 17.81M | -6.78M |
| Cash from Operations | 26.98M | 23.59M | 23.04M | 27.48M | -17.14M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | 5.00M | 5.00M | 5.00M | 5.00M |
| Total Debt Repaid | -13.00M | -- | -- | -- | -- |
| Issuance of Common Stock | 1.77M | 1.72M | 1.94M | 2.13M | 1.72M |
| Repurchase of Common Stock | -646.00K | -654.00K | -140.00K | -77.00K | -78.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.74M | -1.74M | -1.74M | -1.74M | -- |
| Cash from Financing | -13.62M | 4.33M | 5.06M | 5.31M | 6.64M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 13.37M | 27.92M | 28.10M | 32.79M | -10.51M |